We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+2.04%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$23.3B
AUM Growth
-$265M
Cap. Flow
-$917M
Cap. Flow %
-3.93%
Top 10 Hldgs %
47.97%
Holding
197
New
23
Increased
32
Reduced
40
Closed
30

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$386M
2
AON icon
Aon
AON
+$368M
3
CTLT
CATALENT, INC.
CTLT
+$282M
4
CRM icon
Salesforce
CRM
+$266M
5
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$184M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$924M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$262M
3
CSGP icon
CoStar Group
CSGP
+$251M
4
INSP icon
Inspire Medical Systems
INSP
+$135M
5
WAB icon
Wabtec
WAB
+$123M

Sector Composition

Rank Sector Weight
1 Healthcare 29.33%
2 Technology 12.47%
3 Financials 9.64%
4 Industrials 5.44%
5 Communication Services 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TAL icon
76
TAL Education Group
TAL
$6.28B
$14.6M 0.06%
1,365,000
– –
ZYME icon
77
Zymeworks
ZYME
$2.05B
$13.6M 0.06%
1,601,000
– –
PCG icon
78
PG&E
PCG
$38.8B
$12.1M 0.05%
692,323
-579,319
-46% -$10.2M
GDS icon
79
GDS Holdings
GDS
$6.58B
$11.4M 0.05%
1,226,133
+516,133
+73% +$4.17M
ELEV
80
DELISTED
Elevation Oncology
ELEV
$9.72M 0.04%
3,598,418
-288,245
-7% -$1.09M
TWST icon
81
Twist Bioscience
TWST
$9.13B
$9.46M 0.04%
+192,000
New +$7.83M
RIO icon
82
Rio Tinto
RIO
$171B
$9.07M 0.04%
137,500
– –
VTYX
83
DELISTED
Ventyx Biosciences
VTYX
$7.32M 0.03%
3,170,000
– –
ROIV icon
84
Roivant Sciences
ROIV
$26.2B
$7.11M 0.03%
673,000
-225,600
-25% -$2.47M
TECX
85
Tectonic Therapeutic
TECX
$736M
$7.1M 0.03%
+431,010
New +$6.9M
BBOT
86
BridgeBio Oncology
BBOT
$728M
$6.13M 0.03%
600,000
– –
MTAL
87
DELISTED
Metals Acquisition
MTAL
$5.62M 0.02%
410,197
+252,697
+160% +$3.42M
CYTK icon
88
Cytokinetics
CYTK
$10.7B
$5.55M 0.02%
102,400
– –
MGX icon
89
Metagenomi Therapeutics
MGX
$46.5M
$5.48M 0.02%
1,343,201
– –
NVAX icon
90
Novavax
NVAX
$1.47B
$4.78M 0.02%
377,250
-753,750
-67% -$7.58M
RARE icon
91
Ultragenyx Pharmaceutical
RARE
$2.55B
$4.07M 0.02%
99,000
– –
PRME icon
92
Prime Medicine
PRME
$615M
$3.85M 0.02%
750,000
– –
COGT icon
93
Cogent Biosciences
COGT
$6.37B
$3.58M 0.02%
425,161
-36,839
-8% -$279K
IVCP
94
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$3.28M 0.01%
300,000
– –
BACA
95
DELISTED
Berenson Acquisition Corp. I
BACA
$3.04M 0.01%
285,715
– –
BDSX icon
96
Biodesix
BDSX
$281M
$2.87M 0.01%
+93,909
New +$2.68M
ARYD
97
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$2.29M 0.01%
200,000
– –
NRIX icon
98
Nurix Therapeutics
NRIX
$2.77B
$2.27M 0.01%
+108,799
New +$1.69M
AMLX icon
99
Amylyx Pharmaceuticals
AMLX
$4.31B
$2.19M 0.01%
1,150,221
– –
SMC
100
Summit Midstream
SMC
$470M
$2.07M 0.01%
58,214
– –
2 3
4
5 6

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2024 Portfolio in Review

As of Q2 2024, Thomas Steyer held 197 positions worth $23.3B, down 1.1% from $23.6B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Thomas Steyer withdrew a net $917M in Q2 2024, closing 30 positions and reducing 40 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $924M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in Walt Disney worth $356M.

  • Thomas Steyer's largest Q2 2024 buy was Walt Disney: 3,582,168 shares worth $356M.
  • Thomas Steyer added most to Aon in Q2 2024, an estimated $368M increase.
  • Thomas Steyer's biggest Q2 2024 reduction was Alphabet (Google) Class C, cutting an estimated $262M.
  • Thomas Steyer fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $924M.
  • Thomas Steyer's ten largest holdings make up 48% of its $23.3B portfolio in Q2 2024.
  • Thomas Steyer opened 23 new positions and closed 30 in Q2 2024.
  • Thomas Steyer's portfolio value fell 1.1% quarter-over-quarter to $23.3B.

Based on Farallon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.